PLP-B Activators

Chemical activators of PLP-B can regulate its activity through various intracellular signaling pathways by altering the phosphorylation state of the protein. Calcium ionophore A23187 and Ionomycin are two agents that raise intracellular calcium levels, subsequently activating calcium-dependent protein kinases. These kinases then phosphorylate PLP-B, enhancing its activity. Thapsigargin contributes to this cascade by inhibiting the SERCA pump, thereby increasing cytosolic calcium concentration, which also leads to the activation of calcium-dependent kinases that target PLP-B. BAY K8644 further facilitates this process by acting as an L-type calcium channel agonist, which directly leads to an influx of calcium and activation of similar kinases that phosphorylate and activate PLP-B.

Additionally, other chemicals influence the phosphorylation of PLP-B via different pathways. Phorbol 12-myristate 13-acetate (PMA) and 1,2-Dioctanoyl-sn-glycerol (DiC8) mimic diacylglycerol (DAG) and directly activate protein kinase C (PKC), which is known to phosphorylate PLP-B. Forskolin and Dibutyryl cyclic AMP (db-cAMP) work by activating adenylate cyclase and increasing cAMP levels, respectively, which then activates protein kinase A (PKA). PKA also targets PLP-B for phosphorylation. Okadaic Acid and Calyculin A inhibit protein phosphatases 1 and 2A, preventing the dephosphorylation of proteins, thus maintaining PLP-B in a phosphorylated, active state. Anisomycin, through its activation of stress-activated protein kinases such as JNK, also contributes to the phosphorylation and consequent activation of PLP-B. Lastly, (−)-Blebbistatin indirectly influences the activation of PLP-B by altering cytoskeletal dynamics, which can lead to the activation of signaling pathways that culminate in the phosphorylation of PLP-B.